argenx SE (ARGNF)
OTCMKTS
· Delayed Price · Currency is USD
697.42
+72.12 (11.53%)
At close: Jan 29, 2025
argenx SE Employees
argenx SE had 1,148 employees as of December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
$1,662,595
Profits / Employee
-$35,098
Market Cap
39.32B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
SANUWAVE Health | 31 |
Silence Therapeutics | 109 |
argenx SE News
- 4 weeks ago - argenx: Lofty Valuation Diminishes Appeal Amid Autoimmune Expansion (Rating Downgrade) - Seeking Alpha
- 5 weeks ago - Argenx cut to Sell at Deutsche Bank on valuation - Seeking Alpha
- 6 weeks ago - Immunology company argenx estimates higher product net sales from last year - Seeking Alpha
- 6 weeks ago - argenx SE (ARGX) Announces Preliminary 2024 Financial Results and Strategic Priorities for 2025 - GuruFocus
- 6 weeks ago - argenx Highlights 2025 Strategic Priorities - GlobeNewsWire
- 7 weeks ago - argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years - Benzinga
- 2 months ago - argenx SE (ARGX) Gains Approval for VYVDURA in Japan for CIDP Treatment - GuruFocus